The American Society of Clinical Oncology (ASCO) is the leading professional organization for physicians and oncology professionals caring for people with cancer. Through its multidisciplinary network of almost 45,000 oncology professionals, ASCO seeks to provide high-quality resources in education, policy, and clinical research to cancer professionals to advance and improve care for patients with cancer.
The 2018 ASCO Annual Meeting took place from June 1-5, in Chicago, Illinois. The conference brought together oncologists from all over the world to present groundbreaking research and scientific advances in cancer care. The focus of this year’s meeting was expanding the reach of precision medicine.
Journal of Clinical Pathways staff was onsite to provide comprehensive coverage of the Meeting.
Balancing Clinical Trials, Real-World Data to Inform Evidence-Based Cancer Care
Katherine Reeder-Hayes, MD, MBA, MSc, Lineberger Comprehensive Cancer Center, UNC Chapel Hill, described the potential role of real-world evidence as a complement to clinical trials as well as successful implementation of “big data” for real-world evidence generation.
ASCO Town Hall Focuses on Utilization Management Concerns, Initiatives
The ASCO Town Hall session convened to share different perspectives on administrative burden, pharmacy benefit managers, and clinical pathways.
Results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat chemotherapy-induced neutropenia in patients with breast cancer.
Additional coverage from the ASCO Annual Meeting can be found on the conference page.
